Skip to content

Encor Enspire® E4115

by Senorx, Inc.

Encor Enspire E4115 is a mammographic stereotactic biopsy system (FDA Class II; FDA product code KNW, Instrument, Biopsy) made by Senorx, Inc., listed in FDA GUDID since 20 Sep 2016 (UDI-DI 00801741086113), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00801741086113 UDI-DI Date20 Sep 2016ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
ENCOR ENSPIRE® Breast Biopsy System
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Encor Enspire®
Generic name
Mammographic stereotactic biopsy system
Model / Ref / Catalog
E4115
Primary DI / UDI-DI
00801741086113
FDA product code
KNW
GMDN term
Mammographic stereotactic biopsy system
Device class
Class II
Regulation number
876.1075
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Mammographic stereotactic biopsy system.

Other devices from Senorx, Inc.

See all devices from Senorx, Inc. →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)